Medindia

X

Innolife Pharma Inc. acquires rights to breakthrough in non-narcotic chronic pain treatment

Wednesday, May 21, 2008 General News J E 4
Advertisement
MARKHAM, ON, May 20 /PRNewswire-FirstCall/ - Innolife Pharma, Inc. (OtherOTC:INNP.PK - News) is pleased to announce that it has acquired North Americanlicensing rights to the Natural Pain Relief Center non-narcotic proprietarybreakthrough in the treatment of chronic pain.

Today, one in five Americans suffer with chronic pain (~ 60 millionadults) spending approximately $120 Billion a year and the aging baby boomershave reported in surveys more aches and pains than any previous generation.

New Medical Finding with Brain Scans and Functional MRI's

Modern Brain Imaging has revealed that most chronic pain is the result ofthe brain's inability to turn off pain messages from the body. In chronic painthe brain simply is not producing and releasing enough natural pain killers(such as endorphins) to stop the person's suffering. These new medicalfindings show that chronic pain sufferers from headaches, migraines,fibromyalgia, back pain, sciatica, arthritis or a combination of all of them,are caused by a low level of Natural Pain Killer's (such as Endorphins andothers) in the brain, as compared to people without chronic pain.

Over three years of in-clinic testing showed that this breakthroughall-natural program relieved significant chronic pain in 8 out of 10 peopleand with sustainable results. This non-narcotic, combination treatment hasbeen receiving accolades from chronic pain sufferers with major improvement inmood and energy and dramatic decreases in pain levels, allowing a return tonormal life function.

Innolife Pharma Inc. has an aggressive growth plan in place with aprojected target of 95 licensed clinics in 3 years with projected top lineannual revenue in excess of $30 million and a projected bottom line profit ofover $12 million annually (40+%).

With the aging demographic, chronic pain is becoming a larger and largerinternational epidemic. Innolife Pharma Inc. is positioned to be the leadingservice provider in this segment - with a business model that is designed toprovide excellent operating margins and tremendous growth for many years tocome.

About Innolife Pharma Inc.

Innolife Pharma Inc. (PINKSHEETS: INNP) is a small publicly tradedspecialty multi-discipline medical group focusing on licensing the NaturalPain Relief Center all-natural proprietary breakthrough in the treatment ofchronic pain.

FORWARD-LOOKING STATEMENTS:

This release contains forward-looking statements within the meaning andpursuant to the Safe Harbor provisions of the Securities Litigation Reform Actof 1995 and involve risks and uncertainties that may individually or mutuallyimpact the matters herein described, including but not limited to productdevelopment and acceptance, manufacturing, competition, regulatory and/orother factors, which are outside the control of the Company.

SOURCE Innolife Pharma Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Fortune 500s to Convene in Florida, Sharing Insigh...
S
Palatin Technologies Initiates Phase 2 Hypertensio...